Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 111, Issue 12, Pages 1796-1805
Publisher
Springer Nature
Online
2016-09-06
DOI
10.1038/ajg.2016.342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
- (2015) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Measurement of Serum Calprotectin in Stable Patients Predicts Exacerbation and Lung Function Decline in Cystic Fibrosis
- (2015) Philip A. Reid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
- (2015) Emily K. Wright et al. GASTROENTEROLOGY
- Biomarkers of Inflammation in Inflammatory Bowel Disease
- (2015) Bruce E. Sands GASTROENTEROLOGY
- Serum C-reactive Protein and CRP Genotype in Pediatric Inflammatory Bowel Disease
- (2015) Paul Henderson et al. INFLAMMATORY BOWEL DISEASES
- High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis
- (2015) Margalida Calafat et al. INFLAMMATORY BOWEL DISEASES
- Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease
- (2015) Gilles Boschetti et al. INFLAMMATORY BOWEL DISEASES
- Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity
- (2015) Olga Niewiadomski et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review
- (2015) M. Abildtrup et al. JOURNAL OF RHEUMATOLOGY
- P349 Serum calprotectin: a novel biomarker to predict outcome in acute severe ulcerative colitis?
- (2014) N.C. Hare et al. Journal of Crohns & Colitis
- Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach
- (2014) Antoine Obry et al. PLoS One
- Crohn's disease
- (2014) R. Kalla et al. BMJ-British Medical Journal
- The role and utility of faecal markers in inflammatory bowel disease
- (2014) Frank S. Lehmann et al. Therapeutic Advances in Gastroenterology
- Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis
- (2013) Didia Bismara Cury et al. CELLULAR IMMUNOLOGY
- The burden of inflammatory bowel disease in Europe
- (2013) Johan Burisch et al. Journal of Crohns & Colitis
- Serum calprotectin as a biomarker for Crohn's disease
- (2013) M.-A. Meuwis et al. Journal of Crohns & Colitis
- Ulcerative colitis
- (2013) A. C. Ford et al. BMJ-British Medical Journal
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
- (2012) Clas-Göran af Björkesten et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- S100A8 and S100A9 in Cardiovascular Biology and Disease
- (2011) Michelle M. Averill et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?
- (2011) Lajos Sandor Kiss et al. INFLAMMATORY BOWEL DISEASES
- Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
- (2011) James C. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Pediatric modification of the Montreal classification for inflammatory bowel disease
- (2010) Arie Levine et al. INFLAMMATORY BOWEL DISEASES
- Sputum and serum calprotectin are useful biomarkers during CF exacerbation
- (2010) R.D. Gray et al. Journal of Cystic Fibrosis
- Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
- (2009) G T Ho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI
- (2009) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Comparison of gene expression profiles between human and mouse monocyte subsets
- (2009) M. A. Ingersoll et al. BLOOD
- Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis
- (2008) H B. Hammer et al. ANNALS OF THE RHEUMATIC DISEASES
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
- (2008) Michael D. Kappelman et al. GASTROENTEROLOGY
- C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
- (2008) M Henriksen et al. GUT
- Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices
- (2007) Jost Langhorst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More